Barclays lowered the firm’s price target on Archer Daniels (ADM) to $56 from $60 and keeps an Underweight rating on the shares. The company held its 3Q conference call, highlighting continued pressures in crush, biofuel regulatory uncertainties, and ongoing weakness in Human Nutrition, resulting in management affirming last month’s downward guidance revision, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADM:
- Biden admin won’t finalize clean fuel guidance before exit, Reuters reports
- Archer Daniels Midland Schedules Investor Conference Call
- Archer Daniels reports Q3 adjusted EPS $1.09, consensus $1.09
- Archer Daniels backs FY24 EPS view $4.50-$5.00, consensus $4.60
- Archer Daniels options imply 1.5% move in share price post-earnings